Eczema Newswire (Page 6)

Eczema Newswire (Page 6)

Comprehensive Real-Time News Feed for Eczema. (Page 6)

Results 101 - 120 of 394 in Eczema

  1. Skip the Antibiotics for Mild Eczema in KidsRead the original story w/Photo

    Mar 14, 2017 | HON

    Despite widespread use, antibiotics are not an effective treatment for milder cases of the skin condition eczema in children, a new study contends. "This is a good example of a common situation in medicine," said Dr. Michael Grosso.

    Comment?

  2. Antibiotics not effective for clinically infected eczema in childrenRead the original story

    Mar 14, 2017 | PressReleasePoint

    Estimates suggest that 40 per cent of eczema flares are treated with topical antibiotics, but findings from a study involving academics from the University of Bristol's Centre for Academic Primary Care, suggest there is no meaningful benefit from the use of either oral or topical antibiotics for milder clinically infected eczema in children. Eczema is a common condition, especially in young children, and affects around one in five children in the UK.

    Comment?

  3. Study finds antibiotics not effective at treating eczemaRead the original story w/Photo

    Mar 14, 2017 | UPI

    A new study from researchers at Cardiff University in Wales has found antibiotics are not effective at treating mild cases of clinically infected eczema in children. Eczema is a common skin condition that affects 1 in 5 children in the United Kingdom.

    Comment?

  4. Children with mild eczema unlikely to benefit from antibiotics, study showsRead the original story w/Photo

    Mar 14, 2017 | Medical News

    Estimates suggest that 40 percent of eczema flares are treated with topical antibiotics, but findings from a study led by Cardiff University suggest there is no meaningful benefit from the use of either oral or topical antibiotics for milder clinically infected eczema in children. Eczema is a common condition, especially in young children, and affects around 1 in 5 children in the UK.

    Comment?

  5. Antibiotics not effective for clinically infected eczema in children, says StudyRead the original story

    Mar 14, 2017 | Newkerala.com

    London , Mar.14 : According to a new study, Antibiotics which are treated with antibiotics, provides no meaningful benefit from the use of either oral or topical antibiotics for milder clinically infected eczema in children. The study was published in journal Annals of Family Medicine.

    Comment?

  6. UK gives early green light to Sanofi eczema drugRead the original story w/Photo

    Mar 14, 2017 | Reuters

    Sanofi has won an early green light from Britain for its game-changing eczema medicine, boosting the French company's hopes for a product that is also expected to win approval in the U.S. market this month. Britain's medicines regulator has granted dupilumab a positive scientific opinion through its Early Access to Medicines Scheme, meaning patients can get the drug before it is granted formal marketing authorisation, Sanofi said on Tuesday.

    Comment?

  7. Regeneron makes an eye disease drug and a cholesterol drug in East...Read the original story w/Photo

    Mar 13, 2017 | Albany Times Union

    ... drug and a cholesterol drug in East Greenbush. The Tarrytown drug company had $4.1 billion in revenue in 2015. A new eczema treatment could be worth billions of dollars for Tarrytown-based Regeneron Pharmaceuticals, which has its manufacturing ...

    Comment?

  8. 3 Growth Stocks I'd Buy Right NowRead the original story w/Photo

    Mar 11, 2017 | The Motley Fool

    ... Regeneron and Sanofi are slated to receive a go/no-go decision from the FDA in the coming weeks about their new eczema drug candidate, Dupixent. Many believe this drug holds blockbuster potential, so getting the green light could help to reignite ...

    Comment?

  9. Holi 2017: How harmful are artificial colours for the skinRead the original story w/Photo

    Mar 11, 2017 | The Daily Millbury

    ... said. Side effects of Holi colours "Side effects include itching, dryness, exfoliation of skin, erosions of skin and eczema. Skin abrasions can occur due to scrubbing of skin to remove the colours," Poojary said, adding, "Secondary bacterial ...

    Comment?

  10. Altered lipids, skin infections may point to new personalized therapy for atopic dermatitisRead the original story w/Photo

    Mar 8, 2017 | PhysOrg Weblog

    Researchers have discovered a new way to identify the lipids, or fats found in the skin of people who have atopic dermatitis, and compare them to people with healthy skin. This is a fundamental advance in dermatology that could lead to new therapies for millions of people with this debilitating skin problem - atopic dermatitis is one of the most common forms of eczema.

    Comment?

  11. New FDA Approved Steroid-Free Treatment for EczemaRead the original story w/Photo

    Mar 7, 2017 | KMIR 6

    A new FDA approved steroid free cream to treat mild to moderate eczema, a skin condition that affects millions in the U.S. As Janet Zappala shows us, it's a remedy that many have been waiting years for.

    Comment?

  12. Persistent Facial Erythema Treatment Market: North America Dominates...Read the original story w/Photo

    Mar 7, 2017 | SBWire

    ... corticosteroids, and calcineurin inhibitors. In terms of disease type, the market is classified into seborrhea, eczema, rosacea, acne, lupus, and tinea. In terms of distribution channel, the market is classified into hospitals pharmacies, retail ...

    Comment?

  13. New eczema drug promising in early trialRead the original story w/Photo

    Mar 2, 2017 | WFMJ-TV Youngstown

    An experimental drug may significantly reduce the itching and improve the appearance of moderate to severe eczema, a new, preliminary trial finds. Nemolizumab is a man-made, injectable antibody that acts against the protein that has been identified as playing a part in eczema, the international team of researchers said.

    Comment?

  14. Sanofi, Regeneron say latest Dupixent eczema drug tests positiveRead the original story w/Photo

    Mar 4, 2017 | Reuters

    The logo of French drugmaker Sanofi is seen in front of the company's headquarters in Paris, France, October 30, 2014. Drugmakers Sanofi and Regeneron said on Saturday results from a one-year test of their Dupixent product aimed at adults with eczema or moderate-to-severe atopic dermatitis had been positive.

    Comment?

  15. 70 or Older? 3 Stocks You Should Consider BuyingRead the original story w/Photo

    Mar 3, 2017 | The Motley Fool

    ... Eliquis, the rheumatoid arthritis drug Xeljanz, and more. Looking ahead, Pfizer looks poised for growth. It added the eczema drug Eucrisa and the prostate cancer drug Xtandi to its lineup through the acquisitions of Anacor and Medivation, ...

    Comment?

  16. Eczema Skin Disorder 2017: Transplanting 'Good' Bacteria To Kill StaphRead the original story w/Photo

    Feb 24, 2017 | Medical Daily

    Researchers tested 10,000 colonies of bacteria found on skin to figure out which had 'good' bacteria and how often they are found in both healthy skin and skin with eczema - a condition that causes itchy and inflamed skin, usually on the arms, legs, and cheeks. They were able to rid the patients' arms of Staphylococcus aureus , or more commonly known as 'staph,' which makes eczema worse.

    Comment?

  17. Love builds clinic in hometownRead the original story

    Feb 22, 2017 | The Montgomery Advertiser

    ... for the new 4,000-square-foot clinic at 2060 Berryhill Road in Eastchase. It offers a wide range of services, from eczema treatments, to skin cancer surgeries, to chemical peels, phototherapy. There's a spa offering facials, waxing and more, and ...

    Comment?

  18. Community Voice: The benefits of herb gardeningRead the original story w/Photo

    Feb 21, 2017 | Kane Co. Chronicle

    ... came from an herbalist named Althea. A friend suggested she might help alleviate my terrible hay fever and eczema symptoms. She mixed up an herbal tincture, which I faithfully ingested. After a few days I felt much better. That tincture did more for ...

    Comment?

  19. A Billionaire Recently Bought Pfizer Stock -- and So Did IRead the original story w/Photo

    Feb 19, 2017 | The Motley Fool

    ... is growing revenue at a solid pace. Pfizer has also strengthened its lineup through acquisitions. It picked up eczema drug Eucrisa with the buyout of Anacor last year. The company brought prostate cancer drug Xtandi with its acquisition of ...

    Comment?

  20. 3 Beaten-Down Stocks Ready to Bounce BackRead the original story w/Photo

    Feb 10, 2017 | Fox News

    ... current levels near $360. On March 29, the FDA is scheduled to issue a go/no-go decision on Dupixent (dupilumab), an eczema drug with blockbuster sales potential. Management also plans to resubmit Kevzara's application to the FDA this quarter, ...

    Comment?